ECIA ENCISION INC
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 930775 · Fiscal year ends 03/31
Financial factors as of 2025-09-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-3.0%
TTM net income YoY45.0%
TTM EPS YoY50.0%
Revenue 3-yr CAGR-5.3%
Net income 3-yr CAGR—
Margins
Gross margin52.6%
Operating margin-5.1%
Net margin-6.0%
FCF margin-8.6%
EBITDA margin-3.7%
Returns
ROE-21.4%
ROA-10.1%
ROIC (approx.)-15.5%
Asset turnover1.66x
Leverage & solvency
Liabilities / assets54.0%
Debt / equity0.00x
Current ratio2.28x
Interest coverage-5.69x
Cash quality & payout
Operating cash flow / net income1.29x
Accruals ratio2.9%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-03-31 | FY20242024-03-31 |
|---|---|---|
| Income statement | ||
| Revenue | $6.56M | $6.59M |
| Cost of revenue | $3.04M | $3.45M |
| Gross profit | $3.51M | $3.14M |
| R&D expense | $593,152 | $621,894 |
| SG&A expense | $1.40M | $1.52M |
| Operating income | -$171,980 | -$640,783 |
| Interest expense | $43,723 | $62,373 |
| Pretax income | -$220,198 | -$691,783 |
| Income tax | $0 | $0 |
| Net income | -$220,198 | -$691,783 |
| EBITDA | -$90,587 | -$555,565 |
| EPS (basic) | -0.02 | -0.06 |
| EPS (diluted) | -0.02 | -0.06 |
| Weighted avg. shares (diluted) | 11.88M | 11.77M |
| Balance sheet | ||
| Cash & equivalents | $257,433 | $42,509 |
| Receivables | $786,471 | $891,129 |
| Inventory | $1.48M | $1.40M |
| Current assets | $2.61M | $2.43M |
| PP&E, net | $244,757 | $254,004 |
| Intangibles | $171,890 | $164,010 |
| Total assets | $3.67M | $3.81M |
| Current liabilities | $1.58M | $1.07M |
| Total liabilities | $2.02M | $1.98M |
| Shareholders' equity | $1.65M | $1.83M |
| Shares outstanding | 11.88M | 11.86M |
| Cash flow statement | ||
| Operating cash flow | -$54,948 | $144,389 |
| Capital expenditure | $54,415 | $12,050 |
| Free cash flow | -$109,363 | $132,339 |
| Investing cash flow | -$80,025 | -$36,823 |
| Financing cash flow | $349,897 | -$254,023 |
| Depreciation & amortization | $81,393 | $85,218 |
| Stock-based compensation | $46,001 | $53,552 |
Free plan shows the latest 2 periods; Pro shows all 15 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.